Literature DB >> 15703764

Gene therapy progress and prospects: novel gene therapy approaches for AIDS.

R Wolkowicz1, G P Nolan.   

Abstract

Acquired immunodeficiency syndrome (AIDS), caused by human immunodeficiency virus (HIV), kills millions worldwide every year. Vaccines against HIV still seem a distant promise. Pharmaceutical treatments exist, but these are not always effective, and there is increasing prevalence of viral strains with multidrug resistance. Highly active antiretroviral therapy (HAART) consists of inhibitors of viral enzymes (reverse transcriptase (RT) and protease). Gene therapy, first introduced as intracellular immunization, may offer hopes for new treatments to be used alone, or in conjunction with, conventional small molecule drugs. Gene therapy approaches against HIV-1, including suicide genes, RNA-based technology, dominant negative viral proteins, intracellular antibodies, intrakines, and peptides, are the subject of this review.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15703764     DOI: 10.1038/sj.gt.3302488

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  10 in total

1.  Tethering KSRP, a decay-promoting AU-rich element-binding protein, to mRNAs elicits mRNA decay.

Authors:  Chu-Fang Chou; Alok Mulky; Sushmit Maitra; Wei-Jye Lin; Roberto Gherzi; John Kappes; Ching-Yi Chen
Journal:  Mol Cell Biol       Date:  2006-05       Impact factor: 4.272

2.  Random screening for dominant-negative mutants of the cytomegalovirus nuclear egress protein M50.

Authors:  Brigitte Rupp; Zsolt Ruzsics; Christopher Buser; Barbara Adler; Paul Walther; Ulrich H Koszinowski
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

3.  Resistance to human immunodeficiency virus type 1 (HIV-1) generated by lentivirus vector-mediated delivery of the CCR5{Delta}32 gene despite detectable expression of the HIV-1 co-receptors.

Authors:  Qingwen Jin; Jon Marsh; Kenneth Cornetta; Ghalib Alkhatib
Journal:  J Gen Virol       Date:  2008-10       Impact factor: 3.891

4.  Cell-culture assays reveal the importance of retroviral vector design for insertional genotoxicity.

Authors:  Ute Modlich; Jens Bohne; Manfred Schmidt; Christof von Kalle; Sabine Knöss; Axel Schambach; Christopher Baum
Journal:  Blood       Date:  2006-07-06       Impact factor: 22.113

5.  A suicide gene approach using the human pro-apoptotic protein tBid inhibits HIV-1 replication.

Authors:  Peter M Huelsmann; Andreas D Hofmann; Stefanie A Knoepfel; Jasmin Popp; Pia Rauch; Francesca Di Giallonardo; Christina Danke; Eva Gueckel; Axel Schambach; Horst Wolff; Karin J Metzner; Christian Berens
Journal:  BMC Biotechnol       Date:  2011-01-11       Impact factor: 2.563

6.  Targeted delivery of siRNA.

Authors:  Sabrina Oliveira; Gert Storm; Raymond M Schiffelers
Journal:  J Biomed Biotechnol       Date:  2006

7.  Inhibition of human immunodeficiency virus type 1 by RNA interference using long-hairpin RNA.

Authors:  P Konstantinova; W de Vries; J Haasnoot; O ter Brake; P de Haan; B Berkhout
Journal:  Gene Ther       Date:  2006-05-18       Impact factor: 5.250

8.  Femtosecond laser treatment enhances DNA transfection efficiency in vivo.

Authors:  Shaw-Wei D Tsen; Chao-Yi Wu; Avedis Meneshian; Sara I Pai; Chien-Fu Hung; T-C Wu
Journal:  J Biomed Sci       Date:  2009-04-01       Impact factor: 8.410

9.  Inhibition of HIV-1 Viral Infection by an Engineered CRISPR Csy4 RNA Endoribonuclease.

Authors:  Rui Guo; Hong Wang; Jiuwei Cui; Guanjun Wang; Wei Li; Ji-Fan Hu
Journal:  PLoS One       Date:  2015-10-23       Impact factor: 3.240

Review 10.  Therapeutic opportunities of small interfering RNA.

Authors:  Bhoomika R Goyal; Mayur M Patel; Mithil K Soni; Shraddha V Bhadada
Journal:  Fundam Clin Pharmacol       Date:  2009-08       Impact factor: 2.748

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.